Xortx announces results of annual and special meeting of shareholders

Calgary, alberta, sept. 13, 2024 (globe newswire) -- xortx therapeutics inc. ("xortx" or the “company”) (nasdaq: xrtx | tsxv: xrtx | frankfurt: anu), a late-stage clinical pharmaceutical company focused on developing innovative therapies to treat progressive kidney disease, is pleased to announce the results of its annual and special meeting of shareholders (the “meeting”) held thursday, september 12, 2024.
XRTX Ratings Summary
XRTX Quant Ranking